Skip to content

Visual Performance of the Vivity IOL in Post-myopic LASIK and PRK Patients

Visual Performance of the Vivity IOL in Post-myopic LASIK and PRK Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05961046
Enrollment
6
Registered
2023-07-27
Start date
2023-08-17
Completion date
2024-06-13
Last updated
2024-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

The objective is to evaluate visual outcomes and patient satisfaction in patients with a history of myopic LASIK or PRK who will have completed cataract surgery with the Vivity IOL.

Detailed description

This study Prospective, non-interventional, single-center, single-surgeon, single-arm observational study of visual outcomes and patient satisfaction in patients with a history of myopic LASIK or PRK who will have completed cataract surgery with the Vivity IOL. Subjects will be assessed at least 3 months postoperatively. Clinical evaluations will include administration of a satisfaction questionnaire (IOLSAT), as well as measurement of binocular and monocular visual acuities, defocus curve, and manifest refraction.

Interventions

Vivity IOL

Sponsors

Sengi
CollaboratorINDUSTRY
Laser & Corneal Surgery Associates
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Adult (at least 40 years) patients with a history of successful myopic LASIK/PRK and underwent bilateral uncomplicated cataract surgery with non-toric Alcon Vivity IOL at least 3 months before enrollment. * Monocular BCDVA 20/25 or better. * Patients may be \>2 weeks post-YAG capsulotomy for visually significant PCO. * Post-operative sphere ≤0.50D, astigmatism ≤0.50D, and MRSE \< 0.75D.

Exclusion criteria

If any of the following

Design outcomes

Primary

MeasureTime frame
Binocular corrected distance visual acuity3 months after surgery

Secondary

MeasureTime frameDescription
Monocular corrected visual acuity3 months after surgeryAt distance, intermediate, and near
Binocular corrected visual acuity3 months after surgeryAt intermediate and near
Binocular uncorrected visual acuity3 months after surgeryAt distance, intermediate, and near
Monocular uncorrected visual acuity3 months after surgeryAt distance, intermediate, and near
Satisfaction Questionnaire3 months after surgeryThe Intraocular Lens Satisfaction questionnaire (IOLSAT). Lower scores indicate higher spectacle independence and satisfaction.
Visual Disturbance Questionnaire3 months after surgeryLower scores indicate less severe visual disturbances.
Refractive Outcomes3 months after surgeryManifest refraction spherical equivalent (MRSE), residual sphere, astigmatism
Binocular Defocus curve3 months after surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026